Search Demo - PsychoGenics

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Filters

Filters

Therapeutic Areas

Specific Disorders

Filters

Overcoming Mental Health’s Drug Development Challenges with AI

Industrializing Behavioral Testing to Redefine Neuropsychiatric Drug Discovery

We Need a New Prozac: The Demand for Brain Drug Innovation

Mental Health Champions: Why & How Dr. Emer Leahy of PsychoGenics Is Helping To Champion Mental Wellness

The CNS Drug Development Drum Beat is Getting Louder

PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities

GBR Connect Series – Interview with Emer Leahy, PsychoGenics

PsychoGenics’ High Data Security Standards Are Certified by The NIH

PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development

Let’s Find the Right Solution Together

Quick Links

Contact

Address

Email

Phone

Fax